Please login to the form below

Not currently logged in
Email:
Password:

Toujeo

This page shows the latest Toujeo news and features for those working in and with pharma, biotech and healthcare.

Sanofi reveals positive phase 3 results for long-acting insulin Toujeo

Sanofi reveals positive phase 3 results for long-acting insulin Toujeo

The number of patients experiencing severe hypoglycaemia and who experienced hyperglycaemia with ketosis was numerically lower with Toujeo. ... the current indication for Toujeo to include the treatment of T1D in adolescents and children (six years and

Latest news

More from news
Approximately 10 fully matching, plus 26 partially matching documents found.

Latest Intelligence

  • Going the distance Going the distance

    Following hot on the heels of Afrezza has been Toujeo (insulin glargine), the new basal insulin that will be crucial to moving away from Sanofi's dependence on Lantus. ... We are very much encouraging collaboration, so we are working on pairing the

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics